ISBN 10: 1484893581 / ISBN 13: 9781484893586
Gebraucht / Anzahl: 0
Bei weiteren Verkäufern erhältlich
Alle  Exemplare dieses Buches anzeigen

Über dieses Buch

Leider ist dieses Exemplar nicht mehr verfügbar. Wir haben Ihnen weitere Exemplare dieses Titels unten aufgelistet.

Beschreibung:

This Book is in Good Condition. Clean Copy With Light Amount of Wear. 100% Guaranteed. Summary: Chronic ulcers (i.e., ulcers that are unresponsive to initial therapy or that persist despite appropriate care) are estimated to affect over 6 million people in the United States. The incidence is expected to increase as the population ages and as the number of individuals with diabetes increases. Chronic ulcers negatively affect the quality of life and productivity of the patient and represent a substantial financial burden to the health care system. Lower extremity ulcers, especially those attributed to either diabetes, venous disease, or arterial disease comprise a substantial proportion of chronic ulcers. Approximately 15% to 25% of individuals with diabetes develop a foot ulcer at some point in their lifetime and an estimated 12% of those patients require lower extremity amputation. Healing is complicated by diabetic neuropathy and susceptibility to infection. Venous disease accounts for the majority of chronic lower extremity ulcers. Venous hypertension secondary to various causes results in damage to vessel walls and ultimately leads to skin breakdown. Arterial ulcers are less common and are a result of impaired circulation which can affect healing lead to ulceration. Standard treatment for diabetic ulcers includes debridement of necrotic tissue, infection control, local ulcer care, mechanical off-loading, management of blood glucose levels, and education on foot care. For venous ulcers, standard treatment typically includes the use of mechanical compression and limb elevation to reverse tissue edema and improve venous blood flow. Care for ulcers caused by arterial insufficiency is centered on reestablishing blood flow and minimizing further loss of tissue perfusion. If ulcers do not adequately heal with standard treatment, additional modalities may be required - these are often termed "advanced wound care therapies." Lower extremity ulcers are frequently classified etiologically as diabetic, venous or arterial, though overlap may exist. Treatment modalities and wound care therapies are often selected based on the ulcer characteristics as well as patient factors, past treatment, and provider preference. A large and growing array of advanced wound care therapies of different composition and indications have been developed though their efficacy, comparative effectiveness and harm is not well established. The purpose of this review is to synthesize the evidence on therapies for non-healing diabetic, venous, and arterial lower extremity ulcers and is intended to provide an evidence base to guide clinical practice and policy needs within the VA. We recognize that a non-healing ulcer is likely a result of multiple factors and comorbid conditions. We group studies in the review according to the study authors' description of the included ulcer type. The review focuses on FDA-approved therapies and examines clinically relevant outcomes. We address the following key questions: Key Question #1. What are the efficacy and harms of therapies for diabetic ulcers? Is efficacy dependent on ancillary therapies? Does efficacy differ according to patient demographics, comorbid conditions, treatment compliance, or activity level? Key Question #2. What are the efficacy and harms of therapies for venous ulcers? Is efficacy dependent on ancillary therapies? Does efficacy differ according to patient demographics, comorbid conditions, treatment compliance, or activity level? Key Question #3. What are the efficacy and harms of therapies for arterial ulcers? Is efficacy dependent on ancillary therapies? Does efficacy differ according to patient demographics, comorbid conditions, treatment compliance, or activity level?. Buchnummer des Verkäufers

Über diesen Titel:

Bewertung (bereitgestellt von Goodreads):
0 durchschnittlich
(0 Bewertungen)

Inhaltsangabe: Chronic ulcers (i.e., ulcers that are unresponsive to initial therapy or that persist despite appropriate care) are estimated to affect over 6 million people in the United States. The incidence is expected to increase as the population ages and as the number of individuals with diabetes increases. Chronic ulcers negatively affect the quality of life and productivity of the patient and represent a substantial financial burden to the health care system. Lower extremity ulcers, especially those attributed to either diabetes, venous disease, or arterial disease comprise a substantial proportion of chronic ulcers. Approximately 15% to 25% of individuals with diabetes develop a foot ulcer at some point in their lifetime and an estimated 12% of those patients require lower extremity amputation. Healing is complicated by diabetic neuropathy and susceptibility to infection. Venous disease accounts for the majority of chronic lower extremity ulcers. Venous hypertension secondary to various causes results in damage to vessel walls and ultimately leads to skin breakdown. Arterial ulcers are less common and are a result of impaired circulation which can affect healing lead to ulceration. Standard treatment for diabetic ulcers includes debridement of necrotic tissue, infection control, local ulcer care, mechanical off-loading, management of blood glucose levels, and education on foot care. For venous ulcers, standard treatment typically includes the use of mechanical compression and limb elevation to reverse tissue edema and improve venous blood flow. Care for ulcers caused by arterial insufficiency is centered on reestablishing blood flow and minimizing further loss of tissue perfusion. If ulcers do not adequately heal with standard treatment, additional modalities may be required ? these are often termed ?advanced wound care therapies.? Lower extremity ulcers are frequently classified etiologically as diabetic, venous or arterial, though overlap may exist. Treatment modalities and wound care therapies are often selected based on the ulcer characteristics as well as patient factors, past treatment, and provider preference. A large and growing array of advanced wound care therapies of different composition and indications have been developed though their efficacy, comparative effectiveness and harm is not well established. The purpose of this review is to synthesize the evidence on therapies for non-healing diabetic, venous, and arterial lower extremity ulcers and is intended to provide an evidence base to guide clinical practice and policy needs within the VA. We recognize that a non-healing ulcer is likely a result of multiple factors and comorbid conditions. We group studies in the review according to the study authors? description of the included ulcer type. The review focuses on FDA-approved therapies and examines clinically relevant outcomes. We address the following key questions: Key Question #1. What are the efficacy and harms of therapies for diabetic ulcers? Is efficacy dependent on ancillary therapies? Does efficacy differ according to patient demographics, comorbid conditions, treatment compliance, or activity level? Key Question #2. What are the efficacy and harms of therapies for venous ulcers? Is efficacy dependent on ancillary therapies? Does efficacy differ according to patient demographics, comorbid conditions, treatment compliance, or activity level? Key Question #3. What are the efficacy and harms of therapies for arterial ulcers? Is efficacy dependent on ancillary therapies? Does efficacy differ according to patient demographics, comorbid conditions, treatment compliance, or activity level?

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.

Bibliografische Details

Zustand: Used

Beste Suchergebnisse bei AbeBooks

1.

Affairs, U. S. Department of Veterans
ISBN 10: 1484893581 ISBN 13: 9781484893586
Neu Anzahl: > 20
Print-on-Demand
Anbieter
Pbshop
(Wood Dale, IL, USA)
Bewertung
[?]

Buchbeschreibung 2013. PAP. Buchzustand: New. New Book.Shipped from US within 10 to 14 business days.THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Buchnummer des Verkäufers IP-9781484893586

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 19,65
Währung umrechnen

In den Warenkorb

Versand: EUR 3,57
Innerhalb USA
Versandziele, Kosten & Dauer

2.

ISBN 10: 1484893581 ISBN 13: 9781484893586
Neu Anzahl: > 20
Print-on-Demand
Anbieter
BWB
(Valley Stream, NY, USA)
Bewertung
[?]

Buchbeschreibung Buchzustand: New. This item is Print on Demand - Depending on your location, this item may ship from the US or UK. Buchnummer des Verkäufers POD_9781484893586

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 25,55
Währung umrechnen

In den Warenkorb

Versand: Gratis
Innerhalb USA
Versandziele, Kosten & Dauer

3.

Affairs, U. S. Department of Veterans
ISBN 10: 1484893581 ISBN 13: 9781484893586
Neu Anzahl: > 20
Print-on-Demand
Anbieter
Books2Anywhere
(Fairford, GLOS, Vereinigtes Königreich)
Bewertung
[?]

Buchbeschreibung 2013. PAP. Buchzustand: New. New Book. Delivered from our US warehouse in 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND.Established seller since 2000. Buchnummer des Verkäufers IP-9781484893586

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 24,34
Währung umrechnen

In den Warenkorb

Versand: EUR 10,31
Von Vereinigtes Königreich nach USA
Versandziele, Kosten & Dauer

4.

U. S. Department of Veterans Affairs
Verlag: Createspace
ISBN 10: 1484893581 ISBN 13: 9781484893586
Neu Paperback Anzahl: 20
Print-on-Demand
Anbieter
BuySomeBooks
(Las Vegas, NV, USA)
Bewertung
[?]

Buchbeschreibung Createspace. Paperback. Buchzustand: New. This item is printed on demand. Paperback. 184 pages. Dimensions: 10.9in. x 8.4in. x 0.6in.Chronic ulcers (i. e. , ulcers that are unresponsive to initial therapy or that persist despite appropriate care) are estimated to affect over 6 million people in the United States. The incidence is expected to increase as the population ages and as the number of individuals with diabetes increases. Chronic ulcers negatively affect the quality of life and productivity of the patient and represent a substantial financial burden to the health care system. Lower extremity ulcers, especially those attributed to either diabetes, venous disease, or arterial disease comprise a substantial proportion of chronic ulcers. Approximately 15 to 25 of individuals with diabetes develop a foot ulcer at some point in their lifetime and an estimated 12 of those patients require lower extremity amputation. Healing is complicated by diabetic neuropathy and susceptibility to infection. Venous disease accounts for the majority of chronic lower extremity ulcers. Venous hypertension secondary to various causes results in damage to vessel walls and ultimately leads to skin breakdown. Arterial ulcers are less common and are a result of impaired circulation which can affect healing lead to ulceration. Standard treatment for diabetic ulcers includes debridement of necrotic tissue, infection control, local ulcer care, mechanical off-loading, management of blood glucose levels, and education on foot care. For venous ulcers, standard treatment typically includes the use of mechanical compression and limb elevation to reverse tissue edema and improve venous blood flow. Care for ulcers caused by arterial insufficiency is centered on reestablishing blood flow and minimizing further loss of tissue perfusion. If ulcers do not adequately heal with standard treatment, additional modalities may be required these are often termed advanced wound care therapies. Lower extremity ulcers are frequently classified etiologically as diabetic, venous or arterial, though overlap may exist. Treatment modalities and wound care therapies are often selected based on the ulcer characteristics as well as patient factors, past treatment, and provider preference. A large and growing array of advanced wound care therapies of different composition and indications have been developed though their efficacy, comparative effectiveness and harm is not well established. The purpose of this review is to synthesize the evidence on therapies for non-healing diabetic, venous, and arterial lower extremity ulcers and is intended to provide an evidence base to guide clinical practice and policy needs within the VA. We recognize that a non-healing ulcer is likely a result of multiple factors and comorbid conditions. We group studies in the review according to the study authors description of the included ulcer type. The review focuses on FDA-approved therapies and examines clinically relevant outcomes. We address the following key questions: Key Question 1. What are the efficacy and harms of therapies for diabetic ulcers Is efficacy dependent on ancillary therapies Does efficacy differ according to patient demographics, comorbid conditions, treatment compliance, or activity level Key Question 2. What are the efficacy and harms of therapies for venous ulcers Is efficacy dependent on ancillary therapies Does efficacy differ according to patient demographics, comorbid conditions, treatment compliance, or activity level Key Question 3. What are the efficacy and harms of therapies for arterial ulcers Is efficacy dependent on ancillary therapies Does efficacy differ according to patient demographics, comorbid conditions, treatment compliance, or activity level This item ships from La Vergne,TN. Paperback. Buchnummer des Verkäufers 9781484893586

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 25,76
Währung umrechnen

In den Warenkorb

Versand: EUR 3,53
Innerhalb USA
Versandziele, Kosten & Dauer

5.

Affairs, U. S. Department of Veterans; Service, Health Services Research & Development
Verlag: CreateSpace Independent Publishing Platform
ISBN 10: 1484893581 ISBN 13: 9781484893586
Neu PAPERBACK Anzahl: > 20
Anbieter
Russell Books
(Victoria, BC, Kanada)
Bewertung
[?]

Buchbeschreibung CreateSpace Independent Publishing Platform. PAPERBACK. Buchzustand: New. 1484893581 Special order direct from the distributor. Buchnummer des Verkäufers ING9781484893586

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 24,87
Währung umrechnen

In den Warenkorb

Versand: EUR 6,26
Von Kanada nach USA
Versandziele, Kosten & Dauer

6.

U S Department of Veterans Affairs, Health Services Research Deve Service
Verlag: Createspace, United States (2013)
ISBN 10: 1484893581 ISBN 13: 9781484893586
Neu Paperback Anzahl: 10
Print-on-Demand
Anbieter
The Book Depository
(London, Vereinigtes Königreich)
Bewertung
[?]

Buchbeschreibung Createspace, United States, 2013. Paperback. Buchzustand: New. 277 x 213 mm. Language: English . Brand New Book ***** Print on Demand *****.Chronic ulcers (i.e., ulcers that are unresponsive to initial therapy or that persist despite appropriate care) are estimated to affect over 6 million people in the United States. The incidence is expected to increase as the population ages and as the number of individuals with diabetes increases. Chronic ulcers negatively affect the quality of life and productivity of the patient and represent a substantial financial burden to the health care system. Lower extremity ulcers, especially those attributed to either diabetes, venous disease, or arterial disease comprise a substantial proportion of chronic ulcers. Approximately 15 to 25 of individuals with diabetes develop a foot ulcer at some point in their lifetime and an estimated 12 of those patients require lower extremity amputation. Healing is complicated by diabetic neuropathy and susceptibility to infection. Venous disease accounts for the majority of chronic lower extremity ulcers. Venous hypertension secondary to various causes results in damage to vessel walls and ultimately leads to skin breakdown. Arterial ulcers are less common and are a result of impaired circulation which can affect healing lead to ulceration. Standard treatment for diabetic ulcers includes debridement of necrotic tissue, infection control, local ulcer care, mechanical off-loading, management of blood glucose levels, and education on foot care. For venous ulcers, standard treatment typically includes the use of mechanical compression and limb elevation to reverse tissue edema and improve venous blood flow. Care for ulcers caused by arterial insufficiency is centered on reestablishing blood flow and minimizing further loss of tissue perfusion. If ulcers do not adequately heal with standard treatment, additional modalities may be required - these are often termed advanced wound care therapies. Lower extremity ulcers are frequently classified etiologically as diabetic, venous or arterial, though overlap may exist. Treatment modalities and wound care therapies are often selected based on the ulcer characteristics as well as patient factors, past treatment, and provider preference. A large and growing array of advanced wound care therapies of different composition and indications have been developed though their efficacy, comparative effectiveness and harm is not well established. The purpose of this review is to synthesize the evidence on therapies for non-healing diabetic, venous, and arterial lower extremity ulcers and is intended to provide an evidence base to guide clinical practice and policy needs within the VA. We recognize that a non-healing ulcer is likely a result of multiple factors and comorbid conditions. We group studies in the review according to the study authors description of the included ulcer type. The review focuses on FDA-approved therapies and examines clinically relevant outcomes. We address the following key questions: Key Question #1. What are the efficacy and harms of therapies for diabetic ulcers? Is efficacy dependent on ancillary therapies? Does efficacy differ according to patient demographics, comorbid conditions, treatment compliance, or activity level? Key Question #2. What are the efficacy and harms of therapies for venous ulcers? Is efficacy dependent on ancillary therapies? Does efficacy differ according to patient demographics, comorbid conditions, treatment compliance, or activity level? Key Question #3. What are the efficacy and harms of therapies for arterial ulcers? Is efficacy dependent on ancillary therapies? Does efficacy differ according to patient demographics, comorbid conditions, treatment compliance, or activity level?. Buchnummer des Verkäufers APC9781484893586

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 48,35
Währung umrechnen

In den Warenkorb

Versand: Gratis
Von Vereinigtes Königreich nach USA
Versandziele, Kosten & Dauer

7.

U S Department of Veterans Affairs, Health Services Research Deve Service
Verlag: Createspace, United States (2013)
ISBN 10: 1484893581 ISBN 13: 9781484893586
Neu Paperback Anzahl: 10
Print-on-Demand
Anbieter
The Book Depository US
(London, Vereinigtes Königreich)
Bewertung
[?]

Buchbeschreibung Createspace, United States, 2013. Paperback. Buchzustand: New. 277 x 213 mm. Language: English . Brand New Book ***** Print on Demand *****. Chronic ulcers (i.e., ulcers that are unresponsive to initial therapy or that persist despite appropriate care) are estimated to affect over 6 million people in the United States. The incidence is expected to increase as the population ages and as the number of individuals with diabetes increases. Chronic ulcers negatively affect the quality of life and productivity of the patient and represent a substantial financial burden to the health care system. Lower extremity ulcers, especially those attributed to either diabetes, venous disease, or arterial disease comprise a substantial proportion of chronic ulcers. Approximately 15 to 25 of individuals with diabetes develop a foot ulcer at some point in their lifetime and an estimated 12 of those patients require lower extremity amputation. Healing is complicated by diabetic neuropathy and susceptibility to infection. Venous disease accounts for the majority of chronic lower extremity ulcers. Venous hypertension secondary to various causes results in damage to vessel walls and ultimately leads to skin breakdown. Arterial ulcers are less common and are a result of impaired circulation which can affect healing lead to ulceration. Standard treatment for diabetic ulcers includes debridement of necrotic tissue, infection control, local ulcer care, mechanical off-loading, management of blood glucose levels, and education on foot care. For venous ulcers, standard treatment typically includes the use of mechanical compression and limb elevation to reverse tissue edema and improve venous blood flow. Care for ulcers caused by arterial insufficiency is centered on reestablishing blood flow and minimizing further loss of tissue perfusion. If ulcers do not adequately heal with standard treatment, additional modalities may be required - these are often termed advanced wound care therapies. Lower extremity ulcers are frequently classified etiologically as diabetic, venous or arterial, though overlap may exist. Treatment modalities and wound care therapies are often selected based on the ulcer characteristics as well as patient factors, past treatment, and provider preference. A large and growing array of advanced wound care therapies of different composition and indications have been developed though their efficacy, comparative effectiveness and harm is not well established. The purpose of this review is to synthesize the evidence on therapies for non-healing diabetic, venous, and arterial lower extremity ulcers and is intended to provide an evidence base to guide clinical practice and policy needs within the VA. We recognize that a non-healing ulcer is likely a result of multiple factors and comorbid conditions. We group studies in the review according to the study authors description of the included ulcer type. The review focuses on FDA-approved therapies and examines clinically relevant outcomes. We address the following key questions: Key Question #1. What are the efficacy and harms of therapies for diabetic ulcers? Is efficacy dependent on ancillary therapies? Does efficacy differ according to patient demographics, comorbid conditions, treatment compliance, or activity level? Key Question #2. What are the efficacy and harms of therapies for venous ulcers? Is efficacy dependent on ancillary therapies? Does efficacy differ according to patient demographics, comorbid conditions, treatment compliance, or activity level? Key Question #3. What are the efficacy and harms of therapies for arterial ulcers? Is efficacy dependent on ancillary therapies? Does efficacy differ according to patient demographics, comorbid conditions, treatment compliance, or activity level?. Buchnummer des Verkäufers APC9781484893586

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 49,03
Währung umrechnen

In den Warenkorb

Versand: Gratis
Von Vereinigtes Königreich nach USA
Versandziele, Kosten & Dauer

8.

U. S. Department Affairs and Health Services Servi
ISBN 10: 1484893581 ISBN 13: 9781484893586
Neu Anzahl: 1
Anbieter
Castle Rock
(Pittsford, NY, USA)
Bewertung
[?]

Buchbeschreibung Buchzustand: Brand New. Book Condition: Brand New. Buchnummer des Verkäufers 97814848935861.0

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Neu kaufen
EUR 46,92
Währung umrechnen

In den Warenkorb

Versand: EUR 3,57
Innerhalb USA
Versandziele, Kosten & Dauer

9.

U. S. Department of Veterans Affairs
Verlag: CreateSpace Independent Publishing Platform (2013)
ISBN 10: 1484893581 ISBN 13: 9781484893586
Gebraucht Paperback Anzahl: 1
Anbieter
Books Express
(Portsmouth, NH, USA)
Bewertung
[?]

Buchbeschreibung CreateSpace Independent Publishing Platform, 2013. Paperback. Buchzustand: Used: Good. Ships with Tracking Number! INTERNATIONAL WORLDWIDE Shipping available. May not contain Access Codes or Supplements. Buy with confidence, excellent customer service!. Buchnummer des Verkäufers 1484893581

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Gebraucht kaufen
EUR 113,12
Währung umrechnen

In den Warenkorb

Versand: Gratis
Innerhalb USA
Versandziele, Kosten & Dauer